1Juan M. Saavedra. Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic Opportunities[J] 2005,Cellular and Molecular Neurobiology(3-4):485～512
2Daniel W. Lambert,Nicola E. Clarke,Anthony J. Turner.Not just angiotensinases: new roles for the angiotensin-converting enzymes[J]. Cellular and Molecular Life Sciences . 2010 (1)
3Iwai M,,Horiuchi M.Devil and angel in the renin-angiotensin system:ACE-angiotensin II-AT1receptor axis vs.ACE2-angiotensin-(1-7)-Mas re-ceptor axis. Hypertension Research . 2009
4Zhong JC,Guo D,Chen CB,et al.Prevention of angiotensin II-mediated renal oxidative stress,inflammation,and fibrosis by angiotensin-convertingenzyme2. Journal of Hypertension . 2011
5Zhong JC,Yu XY,Lin QX,et al.Enhanced angiotensin converting enzyme2regulates the insulin/Akt signalling pathway by blockade of macro-phage migration inhibitory factor expression. British Journal of Pharmacology . 2008
6Wysocki J,Ye M,Rodriguez E,et al.Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme2:prevention of angiotensin II-dependent hypertension. Journal of Hypertension . 2010
8Krum H,Gilbert RE.Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Journal of Hypertension . 2007
9Ingelfinger JR.Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Current Opinion in Nephrology and Hypertension . 2009
10Zhong JC,Ye JY,Jin HYet al.Tel misartan attenuates aortic hypertrophyin hypertensive rats by the modulation of ACE2and profilin-1expression. Regulatory Peptides . 2011
